Hensley ML - Search Results

1

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.

Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P. Juretzka MM, et al. Among authors: hensley ml. Gynecol Oncol. 2007 Jan;104(1):176-80. doi: 10.1016/j.ygyno.2006.07.027. Epub 2006 Sep 25. Gynecol Oncol. 2007. PMID: 16996584

2

Implementation of disease management guidelines in patients with advanced ovarian cancer.

Hensley ML, Sabbatini P, Spriggs D. Hensley ML, et al. Semin Oncol. 1999 Feb;26(1 Suppl 1):46-51. Semin Oncol. 1999. PMID: 10071973 Review.

3

Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.

Hensley ML, Peterson B, Silver RT, Larson RA, Schiffer CA, Szatrowski TP. Hensley ML, et al. J Clin Oncol. 2000 Mar;18(6):1301-8. doi: 10.1200/JCO.2000.18.6.1301. J Clin Oncol. 2000. PMID: 10715301

4

Screening for ovarian cancer: what we know, what we need to know.

Hensley ML, Castiel M, Robson ME. Hensley ML, et al. Oncology (Williston Park). 2000 Nov;14(11):1601-7; discussion 1608, 1613-6. Oncology (Williston Park). 2000. PMID: 11125943 Free article. Review.

5

Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.

Gemignani ML, Hensley ML, Cohen R, Venkatraman E, Saigo PE, Barakat RR. Gemignani ML, et al. Among authors: hensley ml. Gynecol Oncol. 2001 Jan;80(1):16-20. doi: 10.1006/gyno.2000.6012. Gynecol Oncol. 2001. PMID: 11136563 Clinical Trial.

6

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Hensley ML, et al. Gynecol Oncol. 2001 Jun;81(3):485-9. doi: 10.1006/gyno.2001.6185. Gynecol Oncol. 2001. PMID: 11371143

7

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. Hensley ML, et al. Gynecol Oncol. 2001 Sep;82(3):464-9. doi: 10.1006/gyno.2001.6299. Gynecol Oncol. 2001. PMID: 11520141

8

Identification of prognostic factors in advanced epithelial ovarian carcinoma.

Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ. Chi DS, et al. Among authors: hensley ml. Gynecol Oncol. 2001 Sep;82(3):532-7. doi: 10.1006/gyno.2001.6328. Gynecol Oncol. 2001. PMID: 11520151

9

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D. Barakat RR, et al. J Clin Oncol. 2002 Feb 1;20(3):694-8. doi: 10.1200/JCO.2002.20.3.694. J Clin Oncol. 2002. PMID: 11821450

10

Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.

Dizon DS, Sabbatini PJ, Aghajanian C, Hensley ML, Spriggs DR. Dizon DS, et al. Among authors: hensley ml. Gynecol Oncol. 2002 Mar;84(3):378-82. doi: 10.1006/gyno.2001.6519. Gynecol Oncol. 2002. PMID: 11855873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters